Applied Dna Sciences (NASDAQ:BNBX) Releases Earnings Results

Applied Dna Sciences (NASDAQ:BNBX) released its earnings results on Thursday. The company reported ($0.57) EPS for the quarter, FiscalAI reports. The firm had revenue of $0.61 million for the quarter. Applied Dna Sciences had a negative return on equity of 349.95% and a negative net margin of 1,647.25%.

Applied Dna Sciences Stock Performance

Shares of NASDAQ:BNBX traded up $0.00 during midday trading on Friday, hitting $0.14. 88,013 shares of the company’s stock traded hands, compared to its average volume of 484,908. Applied Dna Sciences has a twelve month low of $0.07 and a twelve month high of $7.15. The company has a market cap of $1.04 million, a PE ratio of -0.00 and a beta of 0.60. The firm’s fifty day moving average price is $0.27 and its two-hundred day moving average price is $0.54.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Applied Dna Sciences in a report on Friday, April 24th. One research analyst has rated the stock with a Sell rating, According to MarketBeat, Applied Dna Sciences presently has a consensus rating of “Sell”.

Applied Dna Sciences Company Profile

Applied DNA Sciences is a U.S.-based biotechnology company that develops and commercializes molecular-level solutions for product authentication, supply chain security and forensic identification. The company’s technologies apply unique DNA markers and laboratory testing methods to tag, track and verify the authenticity of goods and materials, with the goal of combating counterfeiting, diversion and fraud across complex supply chains.

Central to Applied DNA’s offering is a suite of proprietary DNA-based markers and associated assays that can be incorporated into inks, fibers, coatings and other substrates to create tamper-evident, forensic-grade identifiers.